Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInterest Coverage RatioInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on SalesTimes Interest Earned

Oncology Institute (TOI) Return on Capital Employed (2021 - 2025)

Historic Return on Capital Employed for Oncology Institute (TOI) over the last 5 years, with Q3 2025 value amounting to 0.43%.

  • Oncology Institute's Return on Capital Employed rose 500.0% to 0.43% in Q3 2025 from the same period last year, while for Sep 2025 it was 0.43%, marking a year-over-year increase of 500.0%. This contributed to the annual value of 0.43% for FY2024, which is 500.0% down from last year.
  • Per Oncology Institute's latest filing, its Return on Capital Employed stood at 0.43% for Q3 2025, which was up 500.0% from 0.48% recorded in Q2 2025.
  • Oncology Institute's 5-year Return on Capital Employed high stood at 0.05% for Q2 2021, and its period low was 0.49% during Q2 2022.
  • Moreover, its 5-year median value for Return on Capital Employed was 0.43% (2023), whereas its average is 0.37%.
  • Per our database at Business Quant, Oncology Institute's Return on Capital Employed plummeted by -4500bps in 2022 and then skyrocketed by 600bps in 2024.
  • Oncology Institute's Return on Capital Employed (Quarter) stood at 0.25% in 2021, then tumbled by -38bps to 0.34% in 2022, then decreased by -28bps to 0.43% in 2023, then fell by -13bps to 0.49% in 2024, then grew by 12bps to 0.43% in 2025.
  • Its Return on Capital Employed stands at 0.43% for Q3 2025, versus 0.48% for Q2 2025 and 0.48% for Q1 2025.